Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proleukin for Pediatric MDR Idiopathic Nephrotic Syndrome
NCT02455908Phase 2Completed
- Sponsor
- Istituto Giannina Gaslini
- Start
- Feb 2012
- Primary completion
- Aug 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in Idiopathic nephrotic syndrome (INS), sponsored by Istituto Giannina Gaslini. Started Feb 2012; status: completed.
02
Drugs
aldesleukin
03
Conditions
Idiopathic nephrotic syndrome (INS)
Beyond the preview
Go deeper on NCT02455908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02455908.